FMR LLC - BALCHEM CORP ownership

BALCHEM CORP's ticker is BCPC and the CUSIP is 057665200. A total of 287 filers reported holding BALCHEM CORP in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
FMR LLC ownership history of BALCHEM CORP
ValueSharesWeighting
Q3 2023$751,589
-1.4%
6,059
+7.1%
0.00%
Q2 2023$762,351
-28.9%
5,655
-33.3%
0.00%
Q1 2023$1,071,610
+532.2%
8,472
+510.4%
0.00%
Q4 2022$169,518
-8.9%
1,388
-9.0%
0.00%
Q3 2022$186,000
+14.1%
1,525
+21.3%
0.00%
Q2 2022$163,000
-3.6%
1,257
+1.9%
0.00%
Q1 2022$169,000
+186.4%
1,234
+255.6%
0.00%
Q4 2021$59,000
-99.8%
347
-99.8%
0.00%
-100.0%
Q3 2021$30,397,000
-48.7%
209,534
-53.6%
0.00%
-60.0%
Q2 2021$59,309,000
-23.3%
451,853
-26.7%
0.01%
-28.6%
Q1 2021$77,302,000
-19.9%
616,393
-26.4%
0.01%
-22.2%
Q4 2020$96,549,000
+19.4%
837,960
+1.2%
0.01%
+12.5%
Q3 2020$80,876,000
+108.9%
828,390
+103.0%
0.01%
+100.0%
Q2 2020$38,719,000
+78.1%
408,171
+85.3%
0.00%
+33.3%
Q1 2020$21,740,000
+80418.5%
220,225
+82381.3%
0.00%
Q4 2019$27,000
+42.1%
267
+40.5%
0.00%
Q3 2019$19,000
-32.1%
190
-32.6%
0.00%
Q2 2019$28,000
-28.2%
282
-33.8%
0.00%
Q1 2019$39,000
+44.4%
426
+22.4%
0.00%
Q4 2018$27,000
-41.3%
348
-14.3%
0.00%
Q3 2018$46,000
-98.5%
406
-99.0%
0.00%
Q3 2016$3,148,000
-81.7%
40,600
-84.3%
0.00%
-100.0%
Q4 2014$17,182,000
+79.4%
257,835
+52.3%
0.00%
+100.0%
Q3 2014$9,579,000169,3300.00%
Other shareholders
BALCHEM CORP shareholders Q3 2023
NameSharesValueWeighting ↓
SANTA MONICA PARTNERS LP 203,004$25,18119.44%
Montanaro Asset Management Ltd 188,000$23,319,5204.10%
Conestoga Capital Advisors, LLC 1,076,327$133,507,6482.29%
GENEVA CAPITAL MANAGEMENT LLC 763,326$94,682,9372.00%
Tributary Capital Management, LLC 139,116$17,255,9491.63%
WASATCH ADVISORS LP 1,976,930$245,218,3971.55%
Cutter & CO Brokerage, Inc. 41,853$5,191,4091.52%
Laurus Investment Counsel Inc. 19,990$3,342,1741.40%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 37,950$4,707,3180.97%
MOODY ALDRICH PARTNERS LLC 36,613$4,541,4770.86%
View complete list of BALCHEM CORP shareholders